Neurology Today: How and where artificial intelligence works for stroke detection
Nearly every industry is wrestling with how artificial intelligence (AI) will affect its future, and the area of stroke imaging and care is no exception.
Achala Vagal, MD, vice chair of research and professor of radiology in UC’s College of Medicine and a UC Health neuroradiologist, was one of several experts who discussed this topic with Neurology Today.
“As powerful as AI is, I don't think it can ever replace the human expert,” Vagal said. “We cannot take AI as gospel. I call it augmented intelligence: it's one more tool to help us help our patients.
“For me, the paradigm shift is that we have our desktop PACS workstations for viewing images, but the decision-making and communication about triaging the patient is happening on a different platform, on the phone,” Vagal continued. “We radiologists need to stay actively involved with the rest of the stroke team in interpreting and confirming what the AI is saying.”
Read the Neurology Today article.
Featured photo at top of Achala Vagal looking at brain scans. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
College of Medicine celebrates 100% match rate for Class of 2026
March 23, 2026
From local hospitals to the Mayo Clinic, the UC College of Medicine Class of 2026 achieved a 100% match rate for their residency training destinations.
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.